» Authors » Wade Thompson

Wade Thompson

Explore the profile of Wade Thompson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 80
Citations 1198
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibrahim K, Cox N, Lim S, Radcliffe E, Lundby C, Prokopidis K, et al.
BMC Geriatr . 2025 Mar; 25(1):158. PMID: 40055633
Background: Polypharmacy (concomitant prescription of ≥ 5 medications) affects a third of older people, and evidence suggests an association with sarcopenia (loss of skeletal muscle mass/quality, muscle strength, and/or physical...
2.
Hatch S, Seitz D, Bruneau M, Ewa V, Feldman S, Goldberg Y, et al.
Can Geriatr J . 2025 Mar; 28(1):91-102. PMID: 40051590
In Canada, approximately 730,000 people are currently living with dementia. Over 75% will experience behavioural and psychological symptoms of dementia (BPSD). There is a lack of consensus on best practices...
3.
Thompson W
Afr J Prim Health Care Fam Med . 2025 Jan; 16(1):e1-e4. PMID: 39846108
In older adults with type 2 diabetes (T2DM), tight glycaemic control (HbA1c 7%) can result in more harm than benefit, especially when using insulin or sulfonylureas. Older adults are at...
4.
Bahat G, Erdogan T, Can B, Ozkok S, Ilhan B, Tufan A, et al.
Drugs Aging . 2024 Dec; 42(1):57-67. PMID: 39688727
Background: Various explicit screening tools, developed mostly in central Europe and the USA, assist clinicians in optimizing medication use for older adults. The Turkish Inappropriate Medication use in oldEr adults...
5.
Thompson W, Kim J, Carney G, Otte J, Dormuth C
J Gen Intern Med . 2024 Oct; PMID: 39414735
No abstract available.
6.
Carney G, MacLure M, Patrick D, Otte J, Ambasta A, Thompson W, et al.
BMJ Qual Saf . 2024 Oct; PMID: 39414374
Objective: To evaluate the impact of a personalised audit and feedback prescribing report (AF) and brief educational summary (ES) on empiric treatment of uncomplicated lower urinary tract infections (UTIs) by...
7.
Ailabouni N, Thompson W, Hilmer S, Quirke L, McNeece J, Bourke A, et al.
Drugs Aging . 2024 Sep; 41(10):821-831. PMID: 39289289
Background And Objective: As dementia progresses, people living with dementia may take high-risk, unnecessary, or ineffective medicines. Cholinesterase inhibitors (ChEIs) may have benefit in some people with dementia; however, up...
8.
Scott S, Atkins B, DCosta T, Rendle C, Murphy K, Taylor D, et al.
Res Social Adm Pharm . 2024 Aug; 20(11):1047-1057. PMID: 39183076
Background: Less than one third of research evidence is translated into policy or practice. Knowledge translation requires effective dissemination, adoption and finally implementation. These three stages are equally important, however,...
9.
van Poelgeest E, Paoletti L, Ozkok S, Pinar E, Bahat G, Vuong V, et al.
Br J Clin Pharmacol . 2024 Aug; 91(1):38-54. PMID: 39117602
In this systematic review, we report on the effects of diuretic deprescribing compared to continued diuretic use. We included clinical studies reporting on outcomes such as mortality, heart failure recurrence,...
10.
Peixoto C, Choudhri Y, Francoeur S, McCarthy L, Fung C, Dowlatshahi D, et al.
J Am Geriatr Soc . 2024 Jul; 72(11):3567-3587. PMID: 39051828
Background: Clinicians and patients often face a decision to continue or discontinue statins. We examined the impact of discontinuation of statins compared with continuation on clinical outcomes (all-cause mortality, cardiovascular...